AllNewsPhotosVideos
Drug Controller General of India

Drugs Controller General Of India

Drugs controller general of india, Latest News

DCGI gives emergency use authorisation to Covaxin for 6-12 age group - Hindi News | DCGI gives emergency use authorisation to Covaxin for 6-12 age group | Latest national News at Lokmatnews.in

National :DCGI gives emergency use authorisation to Covaxin for 6-12 age group

The Drugs Controller General of India (DCGI) gives restricted emergency use authorisation to Covaxin for the 6-12 age group. ...

Phase 2,3 trial data of India's first mRNA COVID vaccine submitted to DCGI - Hindi News | Phase 2,3 trial data of India's first mRNA COVID vaccine submitted to DCGI | Latest national News at Lokmatnews.in

National :Phase 2,3 trial data of India's first mRNA COVID vaccine submitted to DCGI

Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III trials data of India's first mRNA COVID vaccine to the regulator Drugs Controller General of India (DCGI) on Friday, said sources. ...

SEC recommends permission for Phase 3 trial of Covovax as booster - Hindi News | SEC recommends permission for Phase 3 trial of Covovax as booster | Latest health News at Lokmatnews.in

Health :SEC recommends permission for Phase 3 trial of Covovax as booster

New Delhi, March 6 The Subject Expert Committee of India's apex drugs authority Drugs Controller General of India ... ...

DCGI gives final approval to COVID-19 vaccine Corbevax for 12-18 year olds - Hindi News | DCGI gives final approval to COVID-19 vaccine Corbevax for 12-18 year olds | Latest national News at Lokmatnews.in

National :DCGI gives final approval to COVID-19 vaccine Corbevax for 12-18 year olds

Hyderabad-based pharmaceutical company Biological E on Monday received final approval from Drugs Controller General of India (DCGI) for its COVID-19 vaccine Corbevax, for the age group 12 to 18 years. ...

DCGI permits Bharat Biotech to conduct trials for intranasal booster dose - Hindi News | DCGI permits Bharat Biotech to conduct trials for intranasal booster dose | Latest health News at Lokmatnews.in

Health :DCGI permits Bharat Biotech to conduct trials for intranasal booster dose

New Delhi, Jan 28 In a major development on Friday, the Drugs Controller General of India (DCGI) allowed ... ...

Timeline of India's COVID vaccination drive as it completes one-year today - Hindi News | Timeline of India's COVID vaccination drive as it completes one-year today | Latest national News at Lokmatnews.in

National :Timeline of India's COVID vaccination drive as it completes one-year today

Last year on January 16, India commenced the world's largest vaccination drive to vaccinate its massive population of around 1.38 billion against the COVID-19 infection. ...

Covaxin for Children will take some more time for final approval: Sources - Hindi News | Covaxin for Children will take some more time for final approval: Sources | Latest national News at Lokmatnews.in

National :Covaxin for Children will take some more time for final approval: Sources

The data for Bharat Biotech's Covaxin for Children, COVID-19 vaccine for children, is under evaluation and the process will take some more time for final approval from the Drugs Controller General of India (DCGI), sources said. ...

Tracing the journey of India's fight against COVID-19, development of vaccines and vaccination drive - Hindi News | Tracing the journey of India's fight against COVID-19, development of vaccines and vaccination drive | Latest national News at Lokmatnews.in

National :Tracing the journey of India's fight against COVID-19, development of vaccines and vaccination drive

India's COVID-19 vaccination drive achieved another milestone when the cumulative vaccination coverage crossed the 100 crore mark on Thursday. A total of 100 crore vaccine doses have been administered so far to eligible beneficiaries, as per the Cowi ...